The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
Matthew Greenhawt,Elissa M. Abrams,Marcus Shaker,Derek K. Chu,David A. Khan,Cem Akin,Waleed Alqurashi,Peter D. Arkwright,James L. Baldwin,Moshe Ben-Shoshan,Jonathan A. Bernstein,Theresa Bingemann,Katharina Blumchen,Aideen Byrne,Antonio Bognanni,Dianne E. Campbell,Ronna L. Campbell,Zain Chagla,Edmond S. Chan,Jeffrey Chan,Pasquale Comberiati,Timothy E. Dribin,Anne K. Ellis,David Fleischer,Adam T. Fox,Pamela A. Frischmeyer-Guerrerio,Remi Gagnon,Mitchell H. Grayson,Caroline C. Horner,Jonathan Hourihane,Constance H. Katelaris,Harold Kim,John M. Kelso,David M. Lang,Dennis K. Ledford,Michael Levin,Jay A. Lieberman,Richard Loh,Doug Mack,Bruce Mazer,Giselle Mosnaim,Daniel Munblit,S. Shahzad Mustafa,Anil Nanda,John Oppenheimer,Kirsten P Perrett,Allison Ramsey,Matthew A. Rank,Kara Robertson,Javed Sheikh,Jonathan M. Spergel,David R. Stukus,Mimi L.K. Tang,James M. Tracy,Paul Turner,Anna Whalen-Browne,Dana Wallace,Julie Wang,Susan Waserman,John K. Witry,Margitta Worm,Timothy K. Vander Leek,David B.K. Golden +62 more
TLDR
In this article, a multidisciplinary group of international experts in anaphylaxis composed of allergy, infectious disease, emergency medicine, and front-line clinicians to systematically develop recommendations regarding SARS-CoV-2 vaccine immediate allergic reactions.About:
This article is published in The Journal of Allergy and Clinical Immunology: In Practice.The article was published on 2021-06-18 and is currently open access. It has received 131 citations till now. The article focuses on the topics: Vaccination.read more
Citations
More filters
Journal ArticleDOI
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety.
Nicoletta Luxi,Alexia Giovanazzi,Annalisa Capuano,Salvatore Crisafulli,Paola Maria Cutroneo,Maria Pia Fantini,Carmen Ferrajolo,Ugo Moretti,Elisabetta Poluzzi,Emanuel Raschi,Claudia Ravaldi,Chiara Reno,Marco Tuccori,Alfredo Vannacci,Giovanna Zanoni,Gianluca Trifirò +15 more
TL;DR: In this paper, a review of the potential benefits and risks of COVID-19 vaccines in the special cohorts is presented, including pregnant and breastfeeding women, children/adolescents, immunocompromised people and persons with a history of allergy or previous SARS-CoV-2 infection.
Journal ArticleDOI
Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.
Derek K. Chu,Elissa M. Abrams,David B.K. Golden,Kimberly G. Blumenthal,Anna R. Wolfson,Cosby A. Stone,Matthew S. Krantz,Marcus Shaker,Matthew Greenhawt +8 more
TL;DR: The findings suggest that revaccination of individuals with an immediate allergic reaction to a first SARS-CoV-2 mRNA vaccine dose in a supervised setting equipped to manage severe allergic reactions can be safe.
Journal ArticleDOI
Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper
Annick Barbaud,Lene Heise Garvey,Alessandra Arcolaci,Knut Brockow,Francesca Mori,Cristobalina Mayorga,Patrizia Bonadonna,Marina Atanaskovic-Markovic,Luis Moral,Giovanna Zanoni,Marco Pagani,Angèle Soria,Maja Jošt,Jean-Christoph Roger J-P Caubet,Carmo Abreu,Mona Al-Ahmad,Alberto Alvarez-Perea,Sevim Bavbek,Biagioni Benedetta,Bilò Maria Beatrice,Natalia Blanca-López,Gádor Bogas Herrera,Alessandro Buonomo,Gianfranco Calogiuri,Giulia Carli,Josefina Cernadas,G Cortellini,Gülfem Çelik,Semra Demir,Inmaculada Doña,Berna Dursun Adile,Bernadette Eberlein,Faria Emilia,F. Bryan,Tomaz Garcez,Ignacio Garcia-Nunez,Radosław Gawlik,Aslı Gelincik,Eva Rebelo Gomes,Jimmy Hc Gooi,Martine Grosber,Theo Gülen,F. Hacard,Hoarau Cyrille,Christer Janson,Sebastian L. Johnston,Lukas Joerg,Seçil Kepil Özdemir,Ludger Klimek,Mitja Košnik,Marek L. Kowalski,Semanur Kuyucu,Violeta Kvedariene,Jose Julio Laguna,L Jackson Carla,Susana Marinho,Hans Peter Merk,Elisa Meucci,Martine Morisset,Rosa Muñoz-Cano,F Murzilli,Alla Nakonechna,Florin-Dan Popescu,Grzegorz Porebski,Anna Radice,Frederico S. Regateiro,Heike Röckmann,Antonino Romano,Ravishankar Sargur,Joaquín Sastre,Scherer Kathrin,Sedláčková Lenka,Sobotkova Marta,Terreehorst Ingrid,Regina Treudler,Jolanta Walusiak-Skorupa,Bettina Wedi,Stefan Wöhrl,Mihaela Zidarn,Torsten Zuberbier,Ioana Agache,María José Torres +81 more
TL;DR: Anaphylaxis, which is rare, has been reported after COVID‐19 vaccination, but its management is not standardized.
Journal ArticleDOI
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
TL;DR: The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach as discussed by the authors .
Journal ArticleDOI
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2.
TL;DR: It is possible that BNT162b2 mRNA vaccination serves as a provoking and/or relapsing factor of CSU in individuals with allergic diseases and/ or predisposed autoimmunity.
References
More filters
Journal ArticleDOI
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris,Robert W. Taylor,Robert J. Thielke,Jonathon Payne,Nathaniel Gonzalez,José G. Conde +5 more
TL;DR: Research electronic data capture (REDCap) is a novel workflow methodology and software solution designed for rapid development and deployment of electronic data Capture tools to support clinical and translational research.
Journal ArticleDOI
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P. Polack,Stephen J. Thomas,Nicholas Kitchin,Judith Absalon,Alejandra Gurtman,Stephen Lockhart,John L. Perez,Gonzalo Pérez Marc,Edson D. Moreira,Cristiano Zerbini,Ruth Bailey,Kena A. Swanson,Satrajit Roychoudhury,Kenneth Koury,Ping Li,Warren Kalina,David A. Cooper,Robert W. Frenck,Laura L. Hammitt,Özlem Türeci,Haylene Nell,Axel Schaefer,Serhat Ünal,Dina B. Tresnan,Susan Mather,Philip R. Dormitzer,Ugur Sahin,Kathrin U. Jansen,William C. Gruber +28 more
TL;DR: A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older and safety over a median of 2 months was similar to that of other viral vaccines.
Journal ArticleDOI
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Merryn Voysey,Clemens Sac.,Shabir A. Madhi,Lily Yin Weckx,P M Folegatti,Parvinder K. Aley,Brian Angus,Vicky L. Baillie,Shaun Barnabas,Q E Bhorat,S Bibi,Carmen Briner,P Cicconi,Andrea M. Collins,R Colin-Jones,Clare L. Cutland,Thomas C. Darton,Keertan Dheda,Duncan Cja.,Emary Krw.,Katie J. Ewer,Lee Fairlie,Saul N. Faust,Shuo Feng,Daniela M. Ferreira,Adam Finn,Anna Goodman,Catherine M. Green,Christopher A Green,Paul T. Heath,Christopher Hill,Helen Hill,Ian Hirsch,Hodgson Shc.,Allen Izu,S Jackson,D Jenkin,Joe Ccd.,S Kerridge,Anthonet Koen,Gaurav Kwatra,Rajeka Lazarus,Alison M. Lawrie,A Lelliott,Vincenzo Libri,Patrick J. Lillie,R Mallory,Mendes Ava.,Eveline Pipolo Milan,Angela M. Minassian,Alastair McGregor,Hazel Morrison,Y Mujadidi,Amit J Nana,P J O’Reilly,S D Padayachee,A Pittella,E Plested,Katrina M Pollock,M N Ramasamy,S Rhead,Alexandre Vargas Schwarzbold,Nisha Singh,Andrew Smith,R Song,Matthew D. Snape,Eduardo Sprinz,Rebecca K. Sutherland,R Tarrant,E. Thomson,M E Török,Mark Toshner,Turner Dpj.,Johan Vekemans,Tonya Villafana,Watson Mee.,C J Williams,Alexander D. Douglas,Hill Avs.,Teresa Lambe,Sarah C. Gilbert,Andrew J. Pollard +81 more
TL;DR: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials.
Journal ArticleDOI
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R. Baden,Hana M. El Sahly,Brandon Essink,Karen L. Kotloff,Sharon E. Frey,Rick Novak,David Diemert,Stephen A. Spector,Nadine Rouphael,C. Buddy Creech,John W McGettigan,Shishir Khetan,Nathan Segall,Joel Solis,Adam Brosz,Carlos Fierro,Howard J. Schwartz,Kathleen M. Neuzil,Lawrence Corey,Peter B. Gilbert,Holly Janes,Dean Follmann,Mary A. Marovich,John R. Mascola,Laura Polakowski,Julie E. Ledgerwood,Barney S. Graham,Hamilton Bennett,Rolando Pajon,Conor Knightly,Brett Leav,Weiping Deng,Honghong Zhou,Shu Liang Han,Melanie Ivarsson,Jacqueline Miller,Tal Z Zaks +36 more
TL;DR: The mRNA-1273 vaccine as discussed by the authors is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19.
Journal ArticleDOI
AGREE II: advancing guideline development, reporting and evaluation in health care
Melissa C. Brouwers,Michelle E. Kho,George P. Browman,Jako S. Burgers,Francoise Cluzeau,Gene Feder,Béatrice Fervers,Ian D. Graham,Jeremy M. Grimshaw,Steven E. Hanna,Peter Littlejohns,Julie Makarski,Louise Zitzelsberger +12 more
TL;DR: A strategy was needed to differentiate among guidelines and ensure that those guidelines that vary widely in quality are distinguished.